These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2263021

  • 1. [The effects of oral adsorbent (AST-120) in the experimental model of chronic renal failure--pathophysiological study on renal function, glomerular hypertrophy, mesangial function and glomerular histology].
    Yoshida Y, Sakai T, Asakura K, Sugano M, Ise M, Uehara Y.
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1001-8. PubMed ID: 2263021
    [Abstract] [Full Text] [Related]

  • 2. [Effect of oral adsorbent AST-120 in rats with chronic renal failure--mechanism of progression of renal failure by dietary protein].
    Niimura F, Ise M, Uehara Y, Kumano K, Sakai T.
    Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):261-71. PubMed ID: 1630028
    [Abstract] [Full Text] [Related]

  • 3. [Effect of oral adsorbent (AST-120) in the rat model of chronic renal failure induced by adriamycin].
    Yoshida Y, Ise M.
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1055-9. PubMed ID: 1289605
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure.
    Okada K, Okawa E, Shibahara H, Maruyama T, Maruyama N, Matsumoto K, Takahashi S.
    Kidney Blood Press Res; 2004 Oct; 27(4):218-25. PubMed ID: 15273424
    [Abstract] [Full Text] [Related]

  • 5. Correction by oral adsorbent of abnormal digestive tract milieu in rats with chronic renal failure.
    Okada K, Takahashi S.
    Nephrol Dial Transplant; 1995 Oct; 10(5):671-6. PubMed ID: 7566581
    [Abstract] [Full Text] [Related]

  • 6. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
    Komiya T, Miura K, Tsukamoto J, Okamura M, Tamada S, Asai T, Tashiro K, Kuwabara N, Iwao H, Yoshikawa J.
    Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
    [Abstract] [Full Text] [Related]

  • 7. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation.
    van Goor H, van der Horst ML, Fidler V, Grond J.
    Lab Invest; 1992 May; 66(5):564-71. PubMed ID: 1573851
    [Abstract] [Full Text] [Related]

  • 8. [Study on the initiation time of drug treatment for chronic renal failure].
    Takahashi S, Okada K.
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):765-76. PubMed ID: 8377290
    [Abstract] [Full Text] [Related]

  • 9. The mesangium in the long-term remnant kidney model.
    Schwartz MM, Evans J, Bidani AK.
    J Lab Clin Med; 1994 Nov; 124(5):644-51. PubMed ID: 7964122
    [Abstract] [Full Text] [Related]

  • 10. Effect of ramipril, nifedipine, and moxonidine on glomerular morphology and podocyte structure in experimental renal failure.
    Amann K, Nichols C, Tornig J, Schwarz U, Zeier M, Mall G, Ritz E.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1003-11. PubMed ID: 8671960
    [Abstract] [Full Text] [Related]

  • 11. Effect of an oral adsorbent (AST-120) in rats with daunomycin-induced chronic renal failure.
    Shimizu K, Maeda K, Shibata M, Ise M, Sugano M, Uehara Y.
    Nihon Jinzo Gakkai Shi; 1991 May; 33(5):507-11. PubMed ID: 1895550
    [Abstract] [Full Text] [Related]

  • 12. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T, Akizawa T, Koide K, Koshikawa S.
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [Abstract] [Full Text] [Related]

  • 13. Effects of oral adsorbent in the rat model of chronic renal failure.
    Yoshida Y, Sakai T, Ise M.
    Nephron; 1992 Jun; 62(3):305-14. PubMed ID: 1436344
    [Abstract] [Full Text] [Related]

  • 14. Effects of oral carbonic adsorbent (AST-120) on kidney of early-stage chronic kidney disease rats.
    Tan X, He J, Cao X, Zou J, Liu H, Ding X.
    Ren Fail; 2015 Mar; 37(2):337-42. PubMed ID: 25426870
    [Abstract] [Full Text] [Related]

  • 15. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y.
    Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I, Enomoto A, Niwa T.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [Abstract] [Full Text] [Related]

  • 17. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy.
    Namikoshi T, Tomita N, Satoh M, Sakuta T, Kuwabara A, Kobayashi S, Higuchi Y, Nishijima F, Kashihara N.
    Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482
    [Abstract] [Full Text] [Related]

  • 18. Effects of oral adsorbent AST-120 (Kremezin) on renal function and glomerular injury in early-stage renal failure of subtotal nephrectomized rats.
    Kobayashi N, Maeda A, Horikoshi S, Shirato I, Tomino Y, Ise M.
    Nephron; 2002 Jul; 91(3):480-5. PubMed ID: 12119481
    [Abstract] [Full Text] [Related]

  • 19. Influence of factors in the digestive tract on the progression of chronic renal failure.
    Takahashi S, Okada K, Shimamura T.
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):1-11. PubMed ID: 8336393
    [Abstract] [Full Text] [Related]

  • 20. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z, Niwa T.
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.